Inclusion of Cool Packs Use gel or specialized cooling packs Keep the medication cold
Do glucagonlike peptide1 (GLP1) receptor agonists such as semaglutide, liraglutide, dulaglutide, and tirzepatide improve symptoms of postural orthostatic tachycardia syndrome (POTS) and mastcell activation syndrome (MCAS)?
On average, patients lose 10-20% of their body weight over a 6-12 month period with consistent GLP-1 treatment
A structured approach might include: achieving a stable, healthier weight before discontinuation
It didnt stop anything for me." She had mental health struggles when the drug didn't work for her, she said: "It makes you depressed
In SUSTAIN-6, retinopathy complications were higher (3.0% vs 1.8% with placebo), likely tied to fast blood-sugar improvement in people who already had retinopathy